Clinical bottom line
Uterine artery Doppler (UtA Doppler) screening in the second trimester is a valuable, non-invasive tool for predicting the risk of fetal growth restriction (FGR) and preeclampsia, particularly when combined with maternal characteristics and biochemical markers. Elevated uterine artery pulsatility index (UtA-PI) and abnormal waveform patterns correlate with impaired placental perfusion, which precedes clinical manifestations of FGR. While UtA Doppler alone has moderate predictive accuracy, its integration into multivariable risk models enhances early identification of at-risk pregnancies, enabling targeted surveillance and prophylactic interventions such as low-dose aspirin. However, variability in screening protocols, population heterogeneity, and limited standardization temper its universal application. Ongoing research continues to refine thresholds and combined screening algorithms to optimize clinical utility.
What the evidence shows
Multiple studies and guidelines support the role of uterine artery Doppler in predicting FGR and preeclampsia. The International Federation of Gynecology and Obstetrics (FIGO) recommends first-trimester screening incorporating UtA Doppler with maternal factors and biochemical markers to stratify risk and guide aspirin prophylaxis (Poon et al., 2019). Second-trimester UtA Doppler screening remains relevant, especially where first-trimester screening is unavailable or incomplete.
Hiremath et al. (2024) demonstrated that elevated UtA-PI measured in the second trimester significantly predicts both preeclampsia and FGR, with sensitivity and specificity improved when combined with maternal characteristics. Similarly, Padmalatha et al. (2013) reported that abnormal UtA Doppler waveforms correlated strongly with adverse pregnancy outcomes, including FGR, in an Indian cohort, underscoring its applicability across diverse populations.
Joseph et al. (2024) highlighted the prognostic value of UtA Doppler in the third trimester for ongoing fetal surveillance in pregnancies complicated by suspected FGR, suggesting its utility beyond initial risk stratification. Şirinoğlu et al. (2022) proposed that ratios involving middle cerebral artery and uterine artery pulsatility indices may further refine prediction of negative perinatal outcomes in FGR, indicating evolving Doppler parameter combinations.
Nafisa Anwar et al. (2020) reinforced that second-trimester UtA Doppler screening, when integrated with biochemical markers like placental growth factor (PlGF) and pregnancy-associated plasma protein-A (PAPP-A), improves detection rates of preeclampsia and FGR compared to Doppler alone. This aligns with ROC analyses showing that multivariable models outperform single-parameter approaches (unattributed source from vetted list).
Caveats and uncertainty
Despite promising data, several limitations affect the interpretation and implementation of uterine artery Doppler screening. There is no universal consensus on optimal timing, cutoff values for UtA-PI, or waveform criteria, leading to variability in reported predictive performance. Population differences in baseline risk and Doppler indices necessitate local validation before widespread adoption.
The predictive accuracy of UtA Doppler alone is moderate; false positives and negatives occur, potentially leading to unnecessary interventions or missed cases. Combining Doppler with biochemical markers and maternal risk factors improves accuracy but increases complexity and resource requirements, which may limit feasibility in low-resource settings.
Additionally, the incremental benefit of third-trimester UtA Doppler for monitoring established FGR requires further prospective validation. The role of newer Doppler indices and combined cerebral-uterine artery ratios remains investigational and should be considered hypothesis-generating until confirmed by larger studies.
How this may change practice
Incorporating uterine artery Doppler into routine second-trimester screening protocols can enhance early identification of pregnancies at risk for FGR and preeclampsia, facilitating timely interventions such as aspirin prophylaxis, increased surveillance, and planning for delivery. Clinicians should consider Doppler findings alongside maternal history and biochemical markers to stratify risk more accurately.
For settings lacking comprehensive first-trimester screening, second-trimester UtA Doppler offers a practical alternative to identify high-risk pregnancies. In pregnancies with suspected FGR, serial Doppler assessments including uterine and fetal vessels may guide management decisions.
Future practice may evolve to incorporate combined Doppler indices and novel biomarkers as evidence matures, improving predictive precision. Standardization of measurement techniques and thresholds will be essential to optimize clinical utility and reduce variability.